938 results about "Gastritis" patented technology

The invention provides a method and composition for ameliorating or reducing the symptoms, signs, and markers and for the treatment of irritable bowel syndrome, inflammatory bowel disease or gastritis in a mammal in need thereof, said method comprising administering effective amounts of a pharmaceutically acceptable composition containing at least one probiotic microorganism strain comprising Pediococcus for a time sufficient to ameliorate, reduce or treat at least one symptom, sign, or marker of irritable bowel syndrome, inflammatory bowel disease or gastritis.

A surgical apparatus has a body portion that includes a shaft terminating in a distal head or tip for directing light radiation from the apparatus onto the lining of a body cavity for treating an ailment in a body cavity of a patient as for example a gastrointestinal ailment of a patient such as gastritis, gastric ulcer, duodenal ulcer, gastric cancer, gastric lymphoma, ulcerative colitis, or Crohn's disease as well as for treating diseases of the circulatory system, urogenital systems and other body cavities. During use, the shaft of the apparatus is inserted into a body cavity, e.g., stomach or colon, of the patient to place the distal tip of the shaft in the desired position. The body cavity of the patient is then irradiated with light radiation so as to kill or debilitate microorganisms lining the body cavity without serious destruction of the body tissue of the patient to thereby improve or alleviate one or more of the symptoms of the ailment. A probiotic comprising innocuous bacteria can be administered to the patient to reestablish the growth of normal microbial flora when treating the gastrointestinal tract.

The invention discloses a Chinese medicine composite for treating chronic gastritis and a preparation method thereof. The Chinese medicine composite mainly comprises the following active pharmaceutical ingredients: medicated leaven, fructus hordei germinatus, radish seed, pericarpium citri reticulatae, rhizoma cyperi, rhizoma dioscoreae, fructus aurantii immaturus, jobstears seed, lignum dalbergiae odoriferae, grassleaf sweetflag rhizome, cortex magnoliae officinalis, styrax, tuckahoe, fructus amomi, radix et rhizoma rhei, semen pruni, radix trichosanthis, rhizoma coptidis, honeysuckle flower, dandelion, radix scrophulariae, largehead atractylodes rhizome, radix paeoniae alba, medicated leaven, radix angelicae sinensis and rhizoma corydalis, and the like. The Chinese medicine composite can be prepared to be any common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composite can obviously improve gas pain in the gastric cavity, decreased food appetite, fullness after dinner, sour regurgitation, stuffiness in chest and abdomen, heartburn, feverish dysphoria, gastric upset, fatigue, dry pharynx, stomach ache due to too hungry and full, infantile atrophy and the like, which has definite clinical effect, obvious curative effect and fast desired effect. The Chinese medicine composite also has the advantages of low cost, basically no toxic side effect and the like.

This invention discloses isolated short peptides comprising the amino acid sequence Cys-Glu-Phe-His (CEFH) and analogs thereof as well as compositions comprising CEFH peptides and analogs thereof. The CEFH peptides disclosed herein are effective in mediating the denitration of 3-nitrotyrosines (3-NT) in cellular proteins thereby preventing tissue damage associated with excess nitric oxide (NO) and its reactive species. The CEFH peptides disclosed herein are useful in the treatment of ischemia / reperfusion (I / R) injury of various tissues (e.g., I / R injury of heart muscle associated with heart attack or cardiac surgery, I / R injury of brain tissue associated with stroke, I / R injury of liver tissue, skeletal muscles, etc.), septic shock, anaphylactic shock, neurodegenerative diseases (e.g., Alzheimer's and Parkinson's diseases), neuronal injury, atherosclerosis, diabetes, multiple sclerosis, autoimmune uveitis, pulmonary fibrosis, oobliterative bronchiolitis, bronchopulmonary dysplasia (BPD), amyotrophic lateral sclerosis (ALS), sepsis, inflammatory bowel disease, arthritis, allograft rejection, autoimmune myocarditis, myocardial inflammation, pulmonary granulomatous inflammation, influenza- or HSV-induced pneumonia, chronic cerebral vasospasm, allergic encephalomyelitis, central nervous system (CNS) inflammation, Heliobacterium pylori gastritis, necrotizing entrerocolitis, celliac disease, peritonitis, early prosthesis failure, inclusion body myositis, preeclamptic pregnancies, skin lesions with anaphylactoid purpura, nephrosclerosis, ileitis, leishmaniasis, cancer, and related disorders.

Compositions and methods for treating, reducing, or preventing a disease or symptom such as gingivitis, periodontitis, gastritis, colitis, ileitis, Crohn's disease, chronic inflammatory intestinal disease, inflammatory bowel syndrome, chronic inflammatory bowel disease, celiac disease, ulcerative colitis, a gastric ulcer, a peptic ulcer, a buccal ulcer, a nasopharyngeal ulcer, an esophageal ulcer, a duodenal ulcer, a gastrointestinal ulcer, an autoimmune disorder, or pain. The method includes identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Kits comprising such compositions and instructions on such methods are also contemplated herein.

The invention provides methods of treating and preventing asthma, laryngitis, symptomatic gastroesophageal reflux disease, pregnancy-induced gastroesophageal reflux disease, noncardiac chest pains, coughing, apnea, dyspepsia, inflammatory bowel disease, irritable bowel syndrome, gastritis, stress ulcers, bleeding peptic ulcers, acute gastrointestinal bleeding, infectious enteritis, collagenous colitis, lymphocytic colitis, chronic diarrhea in immunocompromised patients, esophageal ulcers in immunocompromised patients, idiopathic gastric acid hypersecretion, gastroparesis, gastrointestinal motility disorders, Zollinger-Ellison syndrome, short bowel syndrome, emesis, regurgitation, early satiety, chronic sore throat, abdominal pain, abdominal bloating, nausea, sour stomach, diarrhea, constipation, bacterial infections, refractory ulcers, gastrointestinal disorders induced by NSAIDs, Barrett's esophagus, gastrointestinal disorders caused by steroids, gastrointestinal disorders induced by cholinergic compounds, and fungal or viral-induced ulcers in the gastrointestinal tract by administering a therapeutically effective amount of at least one proton pump to a patient in need thereof. The invention also provides on demand relief of symptoms associated with gastroesophageal reflux disease (GERD), and provides relief from symptoms caused by the consumption of excessive amounts of food and / or alcohol by administering a therapeutically effective amount of at least one proton pump inhibitor to a patient in need thereof. The invention also provides methods for treating parasitic infections, such as malaria, by administering a therapeutically effective amount of at least one proton pump inhibitor to a patient in need thereof.

The present invention relates to relates to contrast medium technology and is especially one kind of color gastrointestinal ultrasonic contrast medium. The Chinese medicinal materials including pearl, abalone shell, cuttlebone, bletilla tuber in the same amount are produced into capsule via rinse, drying, crushing, sieving, disinfection and capsulizing. The ultrasonic contrast medium may be used in diagnosing gastritis, gastric ulcer, gastric cancer, duodenal ampulla inflammation, duodenal ampulla ulcer and other gastrointestinal diseases. It has no toxic side effect.

The invention discloses a traditional Chinese patent medicine with the components of plant polysaccharide and bamboo extract for treating medium and terminal cancer, which has a formula as follow: 10 kg of whangee, 5 kg of CV.Ventricousinternode, 10 kg of moso bamboo, 5 kg of palm bamboo, 5 kg of phyllostachys glauca, 10 kg of fishscale bamboo and 5 kg of fortune paulownia bark. A method for preparing the traditional Chinese patent medicine comprises the following steps: adding 50 kg of water into the total 50 kg of the medical materials; decocting the mixture to obtain 200 ml to 400ml of concentrated material; adding mineral trace elements: 0.01 milligrams of calcium, 0.01 milligrams of ferrum, 0.01 milligrams of zinc, 0.01 milligrams of selenium, 0.01 milligrams of iodine and 0.01 milligrams of potassium which are essential to the body into the concentrated material after removing impurities and filtering; finally, fermenting the final mixture to obtain the medicine, and bottling the medicine for use. The traditional Chinese patent medicine has the beneficial effects of treating medium and terminal esophagus cancer, gastric cancer, intestinal cancer, liver cancer, cerebral cancer and other cancers and treating gastritis, gastric ulcer, hepatitis, rhinitis and other inflammation. In addition, the traditional Chinese patent medicine can be also used for treating skin cancer and various kinds of skin diseases by exterior spreading. The traditional Chinese patent medicine takes effect rapidly and has no toxic and side effect.

The invention discloses a compound or its salt shown in the formula (I) and usage of the compound as a potassium competitive acid blocker or a gastric acid secretion inhibitor. The compound has a proton pump (H+ / K+)-ATPase inhibitory effect and can be used for preventing, treating and inhibiting diseases related to gastric acid secretion, such as peptic ulcer, zollinger-ellison syndromes, gastritis, erosive esophagitis, reflux esophagitis and symptomatic gastroesophageal reflux diseases.

The invention pertains to the technical field of chemical pharmaceutical production and particularly provides a novel preparation method of sofalcone which has a general formula (I) structure and is mainly applied to the treatment of gastric ulcer and chronic gastritis. The preparation method adopts 2-hydroxy-4-(3-methyl-2-butene oxygen) hypnone as a starting material and a target compound sofalcone (I) is finally prepared after reactions with four steps. Compared with synthesis technologies provided by the existing literatures, the method simplifies the processing method of intermediate products, improves the quality and yield of products and reduces costs.

Methods for treating or preventing gastritis or gastric injury are disclosed, comprising administering a therapeutically effective amount of an amylin or an amylin agonist. Methods are also disclosed for the treatment of pain, fever, inflammation, arthritis, hypercoagulability, or other conditions for which a non-steroidal anti-inflammatory drug would be indicated, comprising administering an amylin or amylin agonist in conjunction with administering a therapeutically effective amount of a non-steroidal anti-inflammatory agent. Pharmaceutical compositions comprising an amylin or amylin agonist and a non-steroidal anti-inflammatory drug are also disclosed.

The invention relates to a fungus tea drink, in particular to tea fungus and a culture method thereof. The tea fungus is prepared from black tea, green tea, scented tea, sugar, glucose, honey, medicine and water. The tea fungus can help digestion, cure various stomach diseases, contains microorganisms beneficial to a human body, can adjust the physiological functions of the human body, promote metabolism, help digestion, prevent arteriosclerosis, resist cancer, care health and strengthen the physique, and becomes a healthcare drink which is popular around the world. The tea fungus can cure various chronic diseases, such as hypertension, atherosclerosis, coronary heart disease, diabetes, constipation, hemorrhoids, obesity, alopecia areata, white hair, cataracts, rheumatoid arthritis, gastritis, diarrhea, anemia, riboflavin deficiency and the like.

The invention discloses a benign gastritis pathological diagnosis support system and method based on big data deep learning. The system comprises an image data obtaining unit, an image data marking unit, an image database building unit, a CNN (Convolutional Neural Network) building unit and a CNN model training unit, wherein the image data obtaining unit is used for obtaining a normal gastric mucosa tissue slice image and a pathological section image of a previously diagnosed benign gastritis case, and the images are used as input image data; the image data marking unit is used for marking the input image data; the image database building unit is used for classifying and sorting the marked image data provided by the image data marking unit, and building a pathological image database; the CNN building unit is used for building a first CNN model; and the CNN model training unit is used for obtaining the ideal CNN model. Through the benign gastritis pathological diagnosis support system and method, the precise and efficient intelligent film reading can be realized, so that the clinic benign gastritis pathological diagnosis work can be assisted; and the accuracy, the work efficiency and the work continuous state are improved.

The invention provides an intragastric floating tablet for periplaneta americana. The intragastric floating tablet is a tablet prepared from periplaneta americana powder or periplaneta americana extracting solution as an active ingredient and an auxiliary material, wherein the weight ratio of the active ingredient to the auxiliary material is 1:(1-30), preferably 1:(2-20), and more preferably 1:19. The intragastric tablet can stay longer in stomach, can well treat helicobacter pylori infection gastritis, peptic ulcer and gastric cancer, and has a wide market prospect.

The invention discloses a traditional Chinese medicine preparation for curing peptic ulcer, and a preparation method thereof. The traditional Chinese medicine preparation is prepared by taking 1 to 10 parts of white peony root, 1 to 20 parts of white atractylodes rhizome, 1 to 20 parts of atractylodes rhizome and 1 to 10 parts of evodia fruit as the basic bulk drugs according to the parts by weight, and also can be combined with 1 to 10 parts of chickens gizzard-membrane, 1 to 20 parts of rhizoma corydalis, 1 to 20 parts of Chinese cinnamon and 15 to 20 parts of auckandia root. Compared with the prior art, the traditional Chinese medicine preparation has the effects of strengthening the spleen and stomach and promoting qi-circulation and relieving pain, and has good treatment effect for the gastric and intestinal diseases with main symptoms of gastric ulcer, doudenal ulcer, gastritis, abdominal pain and abdominal distention; and the traditional Chinese medicine preparation can reduce the dose for the patients to the utmost extent on the premise of ensuring the therapeutic effect of the drug.

The invention belongs to the technical field of traditional Chinese medicine preparation method, and provides a preparation method of a traditional Chinese medicine used for treating gastritis caused by insufficiency of spleen-yang. According to prior arts, gastritis caused by insufficiency of spleen-yang is commonly treated by using omeprazole, which causes adverse reactions. The technical scheme of the invention is that: traditional Chinese medicines of ginseng, human milk, common jujube, common yam rhizome, wheat, different leaves pseudostellaria root tuber, balck-bone silky fowl, wild cabbage, dried longan pulp, largehead atractylodes rhizome, radix paeoniae alba, American ginseng, ligusticum, lotus seed, pilose asiabell root, sharpleaf galangal fruit, mongolian milkvetch root, Siberian solomonseal rhizome, nonglutinous rice, edible bird nest, dried ginger, bayberry, garden radish seed, carica papaya, roof iris rhizome, carrot, buckwheat, medicated leaven, cydonia oblonga mill, cerealose, honey, and licorice are soaked in water, and are decocted by using a mild fire; the obtained solution is filtered, a slag is removed, and the obtained medicine liquid is the traditional Chinese medicine used for treating gastritis caused by insufficiency of spleen-yang. The method is advantaged in that: the preparation method is simple; toxic and side-effects of the traditional Chinese medicine liquid are low; a treatment course is short; and a recovery rate is high. According to the invention, a good effect can be obtained with the cooperation of monarch and minister medicines. A traditional Chinese medicine preparation is adopted, such that adverse reactions, allergic reactions and toxic reactions caused by western medicines are avoided.

The present invention relates to certain substituted tricyclic acid derivatives of Formula (I) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, myocardial ischemia-reperfusion injury, hypertensive nephropathy, glomerulosclerosis, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, microbial infections and associated diseases, viral infections and associated diseases, diseases and disorders mediated by lymphocytes, auto immune diseases, inflammatory diseases, and cancer.

The invention discloses a medicine for treating chronic gastritis and a preparation method thereof, wherein, the medicine has the ingredients of 7 parts of dangshen, 1-3 parts of parched white atractylodes rhizome, 7-9 parts of tuckahoe, 1-3 parts of liquorice, 2-4 parts of angelica, 5-7 parts of magnolia officinalis, 5-7 parts of pinellia tuberifera, 5-7 parts of dried tangerine peel, 2-4 parts of amomum villosum, 2-4 parts of rhizoma corydalis, 6-8 parts of radix astragali, 8-10 parts of bitter orange, 4-6 parts of goldthread root and 1-3 parts of sanchi; the preparation method is that: (1) the medicine materials are directly ground into powder and prepared into oral preparation according to the conventional pharmacy technique; or (2) the raw material and water are mixed together and decocted so as to prepare the oral preparation by taking the aqueous extract; or (3) the raw material medicine is extracted and purified by a certain method to obtain the composite of active extract, and the oral preparation is prepared according to the conventional pharmacy technique.

The invention provides compositions comprising a plurality of yeast cells, wherein said plurality of yeast cells are characterized by their ability to ameliorate or prevent gastritis in a mammal, said ability resulting from their having been cultured in the presence of an alternating electric field having a specific frequency and a specific field strength. Also provided are methods of making and using these compositions.

Methods for maintaining or improving the gastrointestinal health of animals susceptible to or suffering from poor gastrointestinal health by administering to the animal a gastrointestinal health maintaining or improving amount of a food composition comprising from about 1 to about 20% carbohydrate; from about 3 to about 10% total dietary fiber, wherein the total dietary fiber contains from about 10 to about 40% soluble fiber and from about 90 to about 60% insoluble fiber; and from about 0.1 to about 10% omega-3 fatty acids; wherein the composition has a digestibility coefficient of at least 80. Generally, the compositions are administered to the animal to prevent or treat diarrhea or to improve stool quality. Further, the compositions may be administered in conjunction with one or more probiotics, prebiotics, anti-gastritis drugs, anti-enteritis drugs, or anti-diarrhea drugs, microbial exopolysaccharides, or combinations thereof to maintain or improve gastrointestinal health.

The invention relates to a Chinese medicinal preparation and process for preparing, wherein the main raw materials include goldthread root, pinellia tuber, dried orange peel, poria cocos, licorice root, fresh ginger, bamboo shavings and immature bitter orange. The preparation can be used for treating insomnia, depression, coronary disease, gastritis, viral myocarditis and diabetes.

The invention discloses health-care medicinal liquor with the function of invigorating kidney and a preparation method thereof which belong to the technical field of traditional Chinese medicine. The health-care medicinal liquor is prepared from the following raw materials in weight portion: distilled spirit, and Chinese herbal medicines of aweto, ginseng, fructus schizandrae, medlar, actinolite, male silk moth, astragalus root, herba epimedii, herba cistanches, semen alli tuberosi, yam and tuckahoe. The total effective rate of the health-care medicinal liquor for renal deficiency, renal hypofunction patients, nephropathy, prostatitis, rheumatoid arthritis, cervical spondylopathy and lumbar intervertebral disc protrusion can reach over 90 percent. The health-care medicinal liquor also has auxiliary treatment and health-care function on gastritis, gastric cold, intestinal inflammation, irregular menses, adnexitis, hyperplasia of mammary glands, hypopiesis and arrhythmia. The health-care medicinal liquor has a simple concoction process, available material source, no risk in production, transportation and storage, and wide market prospect.

The invention belongs to the field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine for treating gastritis. The traditional Chinese medicine consists of the following active ingredients in certain parts by weight: dangshen, largehead atractylodes rhizome, hawthorn, astragalus, Chinese yam, dried orange peel, rhizoma corydalis, white paeony root, szechuanlovage rhizome, baikal skullcap root, pinellia ternate, radix angelicae pubescentis, indian buead, rheum officinale, bupleurum, chicken's gizzard-membrane, pseudo-ginseng and divaricate saposhnikoviaroot. The traditional Chinese medicine is specially used for treating gastritis. Multiple medicaments are matched appropriately, so that the curative effect is enhanced under the synergistic or resisting action of the medicaments, the treatment requirements of complex diseases are met, and untoward effects are reduced. The traditional Chinese medicine has a remarkable curative effect, is safe andreliable, is easy to take, and has a good treatment effect on gastritis. As proved by experiments on 760 samples, the total effective rate of the traditional Chinese medicine is up to 96 percent.

The invention relates to a novel oral enteric preparation which is composed of 0.1-1000mg of Grel drugs, or medically acceptable salts, ester or derivatives, 37.5-325mg of aspirin and at least one medically acceptable load, wherein the Grel drugs, or medically acceptable salts, esters or derivatives are clopidogrel, prasugrel, brilinta, sarpogrelate, ozagrel, anagrelide, pamicogrel, or medically acceptable salts, ester or derivatives, preferably, clopidogrel sulfate. The oral enteric preparation is used for curing acute coronary syndrome (ACS), angor pectoris, stroke, myocardial infarction or cardia cerebrovascular diseases of patients. According to the oral enteric preparation, adverse reactions such as functional gastrointestinal disorders, nausea, vomit, gastritis, concealed hemorrhage, ulcer exacerbation and gastrointestinal bleeding caused by strong stimulus of aspirin to stomach can be avoided.

The invention provides a type of flavane (isoflavane) compounds, which have the following structural general formula; the compound has a good inhibitory action on urease, so the compound can be used for preparing medicines for preventing gastritis, gastric ulcer and lithangiuria, and the like; and the invention discloses a preparation method thereof.

The novel positively charged prodrugs of acetylsalicylic acid and its analogues in the general formula(1) 'Structure 1' were designed and synthesized. The compounds of the general formula(1) 'Structure 1' indicated above can be prepared from functional derivatives of ASA or its analogues,(for example acid halides or mixed anhydrides), by reaction with suitable alcohols, thiols, or amines. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and push the pro-drug into the cytosol. The experiment results suggest that the pro-drug, diethylaminoethyl acetylsalicylate. AcOH, diffuses through human skin -400 times faster than acetylsalicylic acid itself and ˆ¼100 times faster than ethyl acetylsalicylate. In plasma, 80% of these pro-drugs can change back to the drug in a few minutes. The pro-drugs can be used medicinally in treating any aspirin-treatable conditions in humans or animals and be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of aspirin, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enables the aspirin to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of aspirin.

The present invention relates to a plaster for relief pain of viscera muscle joint, and a method for preparing the same. To resolve the problems of worse treating effect and side effect using existing medicine, the medicine provided by the invention is prepared from raw materials added plant oil and yellow lead of unsaturated fatty acid by weight rate as follows: 5-15 parts toad, 2-7 parts lbamboo knot cyperus rotundus l, 0.7-2.2 parts jiazhu, 3-10 parts paris, 5-15 parts crab, 2-7 parts seseli mairei wolff, 2-7 parts dragon arum, 2-7 parts herb of alpine yarrow, 2.5-7.5 parts raw radix aconiti kusnezoffii, 3-8 parts curcuma, 2.5-7.5 parts raw monkshood, 3-8 parts zedoary, 4-12 parts zushima, 2-5 parts olibanum, 2-5 parts myrrh, 2-7 parts qianjin vine, 2-7 parts nux vomica, 3-8 parts xugufeng, 4-9 parts angelica, 4-12 parts hawthorn, 2-7 parts raw pinellia ternate, 3-8 parts naoyanghua, 2-5 parts liquorice, 4-12 parts bamboo knot sanchi, 4-12 parts clematis root, 3-7 parts datura stramonium seed, 3-8 parts aconitum pendulum, 0.02-0.08 moschus. The plant oil is 50-150 parts tung oil and 30-90 parts black sesame oil. The weight rate of plant oil and yellow lead is 120-200 / 14-22. The medicine has wide application effect, and is suitable for treating pain of viscera muscle joint, long chronic illness. The medicine also has obvious cure effects without toxic side effect for treating acute or chronic gastritis, enteritis, diarrhea, dysmenorrhea, low back pain, neck and lumbar disc herniation, orthopaedics and traumatology. The medicine has effects of promoting circulation of qi and blood, clearing meridians and collaterals, using poisons as antidotes, dehydration detumescence, resolving the nodule, promoting blood circulation and removing blood stasis, dispelling wind chill and dampness syndromes, and can reach aim at both temporary solution and permanent control.

The invention relates to a traditional Chinese medicinal composition for treating gastrointestinal tract, in particular to a medicinal composition for treating gastrointestinal tract diseases such as acute and chronic gastritis, enteritis, gastric ulcer, superficial gastritis, gastric acid, gastrectasia, indigestion and the like. The invention also relates to a preparation of the medicinal composition. The traditional Chinese medicinal composition for treating gastrointestinal tract comprises the medicaments in percentage by weight: 10-25 parts of red ginseng, 10-23 parts of poria, 8-20 parts of bighead atractylodes rhizome, 10-25 parts of rhizoma ligustici wallichii, 10-25 parts of rhizoma atractylodis, 10-25 parts of cyperus rotundus, 10-25 parts of medicated leaven, 10-25 parts of gardenia, 10-23 parts of betelnut, 8-20 parts of radix aucklandiae, 5-15 parts of liquorice, 5-8 parts of malt and 10-25 parts of hawthorn. The medicinal composition for treating the gastrointestinal tract is orally taken and has the efficacies of regulating the flow of qi, comforting the stomach, diminishing inflammation, killing pain, repairing gastrointestinal mucosa and ulceration, enhancing gastrointestinal motility, adjusting gastric acid secretion, promoting digestive absorption and the like.

The present invention discloses a health preserving composition and application thereof. The health preserving composition comprises 10-80 parts by weight of whole grain and medicinal and edible traditional Chinese medicinal materials, 0-30 parts by weight of fruit and vegetable powder, 1-10 parts by weight of freeze-dried probiotic powder and 3-30 parts by weight of prebiotics. After taking of the health preserving composition, constipation and loose stool symptoms may be improved significantly. By long-term use of the health preserving composition, chronic gastritis, enteritis and the like can be significantly improved. By improving of gastrointestinal functions, high blood fat, high blood sugar and various types of chronic liver injuries and other chronic diseases can be improved.